NY-EMPIRE-STATE-REALTY
21.11.2023 20:59:26 CET | Business Wire | Press release
The Empire State Building (ESB) today announced the details of its annual holiday festivities. Celebrations through the end of the year will include seasonal holiday décor, visits from Santa Claus, pop ups, and special tower lightings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231121955174/en/
Most Wonderful Time of the Year: Empire State Building Announces Fan-Favorite Holiday Programs to Include 20th Anniversary Elf Activations, Classic Holiday Décor, Festive Pop-Ups, Special Lightings and More (Photo: Business Wire)
“The holiday season is upon us, and we are excited to provide our guests with one-of-a-kind, holiday-themed experiences here at the Empire State Building,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This year’s visitors are in for lots of treats -- from photos with Santa to elaborate holiday decorative displays and dedications to the Empire State Building’s co-star, ‘Elf,’ to celebrate the film’s 20th anniversary.”
Deck the Halls
Ornaments, wreaths, tinsel, and bows with silver and gold accents adorn the entire Observatory Experience with a large, bright menorah in front of the two-story building model. Inspired by Santa’s workshop, guests can take their holiday photos on the Empire State Building’s 80th Floor in a snowy corner display with Christmas trees, wrapped presents, a cozy fireplace backdrop, and Santa’s oversized chair.
The building’s landmark Fifth Avenue Lobby, that can be visited after conclusion of guests’ visits to the Observatory, is adorned with hanging holiday lights, wreaths, and an embellished Christmas tree. The iconic Fifth Avenue windows depict snowy scenes of Buddy the Elf and his friends as he travels from the North Pole to the “World’s Most Famous Building.” From Nov. 27 through Dec. 29, tenants and visitors who pass through the Fifth Avenue Lobby from Monday through Friday will hear festive holiday tunes performed by professional pianists.
Santa Claus is Comin’ to Town
On Dec. 2, 9, 11, 13, 16, 18, 20, and 22, Santa Claus himself will collect wish lists, spread holiday cheer, and pose for photos with Observatory guests in his own decorated corner on the 80th Floor. For more information on times, please visit esbnyc.com.
ESB Celebrates the 20th Anniversary of ‘Elf’
The beloved Christmas comedy features Buddy the Elf, who in the famous 2003 film travels to meet his father at his office in the Empire State Building. To celebrate the Christmas classic and the Empire State Building’s lead role in the film, ‘Elf’ will take over the Observatory with themed décor in the building’s Fifth Avenue windows and on the 86th Floor Observatory.
Fans can purchase a special ticket to view ‘Elf’ at one of four screenings on the Observatory’s 80th Floor on Sunday, Dec. 3, 10, 13 and 17. Tickets will include holiday-themed drinks and snacks, and full access to ESB’s second floor museum and 86th Floor Observatory. Tickets can be purchased here.
Baby It’s Cold Outside!
Nov. 23 through Jan. 7 from 10 a.m. to 8:00 p.m., S’mores N’more will pop up to sell their famed hot chocolate with oversized marshmallows to guests who purchase tickets to the 86th Floor Observation deck. Special flavors will include:
- “The Buddy” -- inspired by ‘Elf’, a classic hot chocolate with whipped cream, a pop tart marshmallow, M&Ms, chocolate, and a maple syrup drizzle
- “The King” -- inspired by “Kong” himself, a classic hot chocolate with whipped cream, a banana chocolate chip marshmallow, chocolate and banana poke sticks, and cocoa dust
- “Christmas in the Clouds,” a peppermint hot chocolate with whipped cream, a peppermint marshmallow, a York peppermint patty, and Christmas sprinkles
The Empire State Building’s world-famous outdoor Observatory is also equipped with heaters on the 86th Floor Observation Deck during the chillier months to provide guests with a comfortable viewing experience.
Holiday Lightings
The Empire State Building’s world-famous tower lights will shine throughout the holiday season with dedicated lightings for Thanksgiving, Chanukah, Christmas, and New Year’s Eve. The Empire State Building will also debut its annual holiday music-to-light show.
The Empire State Building’s world-famous Observatory Experience recently underwent a $165 million reimagination that features an interactive museum with nine galleries, brand-new host uniforms, and iconic Observatories on the 86th and 102nd floors. The Observatory Experience was recently named #1 attraction in the U.S. for the second consecutive year by TripAdvisor travelers. Text CONNECT to 274-16 to receive information about each Empire State Building tower lighting. More information about the Empire State Building can be found online.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the US for the second year in a row in Tripadvisor’s 2023 Travelers’ Choice Awards: Best of the Best, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust, Inc.
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231121955174/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
